GHK-Cu sits at an unusual intersection in peptide research: it is one of the most-studied copper-binding tripeptides in the wound-healing and tissue-remodelling literature, and simultaneously one of the most frequently mis-reconstituted compounds in research settings — not because of anything exotic in the molecule, but because investigators encounter 50mg and 100mg vials and assume a binary protocol difference exists. There is no difference in the peptide. The math — and how that math interacts with protocol duration, sampling frequency, and stability windows — is what separates a well-designed experiment from a wasted vial. If you want to buy GHK-Cu UAE and run a coherent research protocol, this is the guide to read before you order.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched GHK-Cu across all 7 emirates, with ghk-cu same day Dubai dispatch and next-day delivery to Abu Dhabi, Sharjah, RAK, Fujairah, Ajman and UAQ. Both 50mg and 100mg vials are in stock now at /buy-ghk-cu-uae/.
GHK-Cu (glycine-histidine-lysine copper(II)) is a naturally occurring tripeptide first isolated from human plasma albumin. The copper(II) ion chelated to the GHK backbone is not incidental — it is central to the molecule's activity. Copper is required as a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin fibres in the extracellular matrix. The tripeptide carrier increases local copper bioavailability far beyond what free ionic copper achieves, directing it to sites of tissue turnover rather than allowing systemic distribution.
The peer-reviewed literature on GHK-Cu clusters around three research domains, all underpinned by the references investigators cite most often:
The practical implication for protocol design: GHK-Cu does not behave as a simple linear dose-response compound. Getting the reconstitution concentration right — and selecting the vial size that matches your protocol duration — has direct consequences for research quality.
Both vials from REVIVE LAB UAE contain the same HPLC-verified GHK-Cu copper chelate. The difference is purely mass, and how that mass interacts with reconstitution volume, protocol duration, and the reconstituted-solution stability window.
| Factor | GHK-Cu 50mg Vial | GHK-Cu 100mg Vial |
|---|---|---|
| Total peptide mass | 50 mg | 100 mg |
| Ideal protocol duration | Short (1–3 week study windows) | Extended (4–8+ week windows) |
| Reconstitution frequency | Higher (smaller total volume per vial) | Lower (single reconstitution serves longer) |
| Cost-per-mg | Higher unit cost per mg | Lower unit cost per mg |
| Reconstituted-volume waste risk | Lower (less solution sits open) | Higher if reconstituted all at once early in a short study) |
| Batch consistency across parallel arms | May require multiple vials | Single vial covers multiple parallel arms |
The clearest use-case for the 50mg vial: short protocol windows, lower-volume sampling designs, and pilot studies where a single vial covers the full experiment with minimal reconstituted-solution held in storage. The 100mg vial is the better choice for extended protocols, parallel study arms requiring consistent lot material, and investigators who want to minimise reconstitution events as a source of variability. Both are in stock at REVIVE LAB UAE — ghk-cu in stock UAE status is updated daily.
The most common research preparation error is an inconsistent BAC water volume, producing a concentration that does not match the intended protocol. The tables below cover the four most practical configurations for each vial size, calibrated to a U-100 insulin syringe (100 IU = 1.0 mL; 1 IU = 10 µL). Reconstitute slowly — direct the BAC water stream down the inner wall of the vial, never jet directly onto the lyophilized cake. Swirl gently; do not vortex. GHK-Cu is highly water-soluble and reconstitutes readily, yielding a characteristic blue-green solution (the copper chelation colour). Turbid or colourless solutions indicate a quality issue — contact your supplier.
| BAC Water Added | Concentration | Dose per 1 IU (10 µL) | Dose per 10 IU (0.1 mL) | Total Doses at 10 IU |
|---|---|---|---|---|
| 2.5 mL | 20 mg/mL | 0.20 mg | 2.0 mg | 25 |
| 5.0 mL | 10 mg/mL | 0.10 mg | 1.0 mg | 50 |
| 10.0 mL | 5 mg/mL | 0.05 mg | 0.5 mg | 100 |
| 25.0 mL | 2 mg/mL | 0.02 mg | 0.2 mg | 250 |
| BAC Water Added | Concentration | Dose per 1 IU (10 µL) | Dose per 10 IU (0.1 mL) | Total Doses at 10 IU |
|---|---|---|---|---|
| 5.0 mL | 20 mg/mL | 0.20 mg | 2.0 mg | 50 |
| 10.0 mL | 10 mg/mL | 0.10 mg | 1.0 mg | 100 |
| 20.0 mL | 5 mg/mL | 0.05 mg | 0.5 mg | 200 |
| 50.0 mL | 2 mg/mL | 0.02 mg | 0.2 mg | 500 |
Key observation from the tables: a 50mg vial at 5 mL BAC water and a 100mg vial at 10 mL BAC water produce the same 10 mg/mL concentration. The 100mg option simply doubles the total working volume. For investigators running parallel study arms where batch consistency matters — as it does in any comparative experiment — the 100mg single-vial approach eliminates inter-vial variability from the design. For single-arm pilot work, the 50mg vial gives identical concentration options at lower upfront cost.
The published literature on GHK-Cu does not anchor on a single standard research dose the way that, for example, the tesamorelin lipodystrophy trials anchored on 2 mg/day SC. Pickart and Margolina (2018) review a wide range of in-vitro and in-vivo concentrations that vary substantially by tissue type, model system, and endpoint. This is a feature, not a limitation — protocol flexibility in GHK-Cu research is high. What the literature consistently implies, however, is that two variables directly determine vial-size selection:
The Campbell et al. (2012, BMC Genomics) gene-expression work used GHK to identify transcriptomic signatures across DNA repair, antioxidant, and proteasomal pathways. Protocols targeting these endpoints typically use acute exposures followed by harvest and qPCR or microarray analysis — short windows where the 50mg vial is the natural fit. Wound-closure and tissue-remodelling endpoints (aligned with Pickart 2008, Advances in Wound Care) use longer observation periods — daily administration with wound measurements at 48–72h intervals — where the 100mg vial's extended working volume is more practical. Extracellular matrix and collagen endpoints (Pickart and Margolina 2018) sit between these extremes: typical fibroblast experiments run 5–14 days, making either vial size workable depending on study arm count.
For UAE-based investigators sourcing GHK-Cu in the UAE, the 50mg vial is the standard entry point for pilot and feasibility work; the 100mg is the right choice for scaled, longer-window, multi-arm experiments. REVIVE LAB UAE applies the same HPLC purity standard and lot-COA process to both sizes — there is no quality differential between the two, only scale.
The copper chelate in GHK-Cu is not a cosmetic feature of the molecule — it is mechanistically load-bearing. Pickart and Margolina (2018) explicitly note that the copper(II) coordination geometry is central to GHK-Cu's biological interactions with collagen synthesis machinery and DNA repair signalling. A GHK-Cu preparation that has lost its copper — through improper synthesis, degradation, contaminated starting material, or poor cold-chain handling — is effectively a structurally compromised, and potentially inactive, compound. The blue-green colour of properly reconstituted GHK-Cu is a useful qualitative indicator; it is not a substitute for verified lot-level data.
This is why REVIVE LAB UAE includes lot-COA with every GHK-Cu dispatch confirming both HPLC peptide purity and copper chelation. Every shipment is dispatched in cold-chain insulated packaging validated for UAE summer ambient temperatures — critical when ghk-cu Dubai 24h delivery means transit through courier networks that operate at 40°C+ in summer months. Vials ship lyophilized and sealed, in the most stable form, for maximum integrity on arrival.
For researchers in the UAE, cold-chain logistics are as critical as peptide purity. A GHK-Cu vial that sits in an ambient-temperature courier vehicle for four hours in a Dubai summer has degraded before it reaches the research site. REVIVE LAB UAE runs refrigerated courier dispatch from Dubai, covering every emirate with defined delivery windows:
| Emirate / Key Areas | Delivery Window | Cash on Delivery | Cold-Chain |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, DIFC, Downtown, Palm Jumeirah, JVC, Jumeirah, Emirates Hills) | Same-day, 4–8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas Island, Saadiyat, Reem Island, Al Raha) | Next-day, 18–24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8–18 hours | Yes | Yes |
| Ajman | Next-day, 18–24 hours | Yes | Yes |
| Ras Al Khaimah (RAK) | Next-day, 18–24 hours | Yes | Yes |
| Fujairah | Next-day, 24 hours | Yes | Yes |
| Umm Al Quwain (UAQ) | Next-day, 18–24 hours | Yes | Yes |
All shipments use plain unbranded outer cartons as standard. Payment is flexible: cash on delivery Dubai is accepted across all seven emirates, and USDT crypto pay via Binance Pay (TRC20 network) is available for researchers preferring digital settlement — with a 5% pre-pay discount applied automatically. This makes REVIVE LAB UAE one of the only peptides UAE suppliers combining full cold-chain logistics with dual payment options.
Researchers in Dubai who order before 2pm qualify for ghk-cu same day Dubai dispatch — vials typically arrive within 4–8 hours. The full product listing, lot-COA access and ordering process are at /buy-ghk-cu-uae/.
REVIVE LAB UAE stocks both GHK-Cu 50mg and 100mg vials with HPLC purity verification and lot-level COA confirming copper chelation. Same-day delivery applies to all Dubai orders placed before the daily cut-off — reaching Dubai Marina, JBR, Business Bay, DIFC, Downtown, Palm Jumeirah, JVC and Jumeirah within 4–8 hours. Abu Dhabi, Sharjah and all remaining emirates receive next-day delivery within 24 hours. Both cash on delivery and USDT crypto pay are accepted. Current stock and ordering at /buy-ghk-cu-uae/.
The peptide is identical in both vials — the difference is total mass and working volume. A 50mg vial with 5 mL BAC water gives 10 mg/mL; a 100mg vial with the same 5 mL gives 20 mg/mL — double the concentration per unit volume. Adding 10 mL to the 100mg vial brings it back to 10 mg/mL, matching the 50mg configuration but with double the total volume. Investigators running extended protocols or parallel arms favour the 100mg vial for batch consistency and reduced reconstitution frequency. Short pilot studies and small-sample designs typically use the 50mg vial to minimise the amount of reconstituted solution held in storage beyond its use window. Both are confirmed ghk-cu in stock UAE at REVIVE LAB UAE.
REVIVE LAB UAE's GHK-Cu vials are the pre-formed copper(II) chelate — the GHK tripeptide with the copper ion already coordinated at synthesis. No separate copper addition is required. The blue-green colour of the reconstituted solution is a visual indicator of intact chelation. Pickart and Margolina (2018, Cosmetics) emphasise that the copper coordination geometry is central to GHK-Cu's research activity profile, making the pre-chelated, COA-confirmed form the correct research-grade material. A colourless solution after reconstitution is a red flag indicating copper loss or product degradation — contact REVIVE LAB UAE for replacement.